Maureen Nagle

Special Counsel
Full contact info

Experience

Senti Biosciences Sells Certain Assets to Celadon Partners

August 14, 2023

Cooley advised Senti Biosciences, a biotechnology company, on its sale of certain assets – including its manufacturing facility and chemistry, manufacturing, and controls capabilities – to Celadon Partners.

Read more

Related contacts

Maureen Nagle
Special Counsel, Washington, DC
Chrystal Cantrelle
Associate, Washington, DC
Rena Kaminsky
Special Counsel, Palo Alto
Freddy Yip
Associate, Hong Kong
Peter Crain
Special Counsel, Reston
Alanna B Zuchelli
Associate, Reston
Ross Eberly
Partner, Santa Monica
Marya Postner
Partner, Palo Alto
Helen Luu
Associate, Palo Alto
Aric Wu
Partner, New York
Rachel Thorn
Partner, New York
Barbara Mirza
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Dee Bansal
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
J. Brian Stalter
Special Counsel, New York
Annie Froehlich
Partner, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Zack Gong
Associate, Shanghai
Nicholas Balenger
Associate, Reston
Ajay Athavale
Associate, San Francisco
Sarah Oliai
Associate, Washington, DC
Leina Verrier
Associate, Santa Monica
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Parse.ly Agrees to Sell to Automattic

March 4, 2021

Cooley advised Parse.ly on its agreement to sell to Automattic, a developer of an open-source content management system built to democratize publishing and commerce. Partner Stephane Levy and Daniel Peale led the Cooley team advising Parse.ly, a data analytics platform.

Related contacts

Stephane Levy
Partner, New York
Andrew Gunther
Associate, New York
Daniel Peale
Partner, Washington, DC
Maureen Nagle
Special Counsel, Washington, DC

Related Practices & Industries

Turnstone Biologics to Acquire Myst Therapeutics

January 21, 2021

Cooley advised Turnstone Biologics, a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, in its acquisition of Callifornia-based Myst Therapeutics, a privately held biotechnology company focused on advancing novel T-cell therapies for solid tumors. Partner Kevin Cooper led the Cooley team advising Turnstone Biologics.

Read more

Related contacts

Kevin Cooper
Partner, New York
Maureen Nagle
Special Counsel, Washington, DC
Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Eileen Marshall
Partner, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Ross Eberly
Partner, Santa Monica
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Twin Point Capital Sells Majority Interest in Blue Stream

June 11, 2020

Cooley advised Twin Point Capital, a principal investment firm with offices in Palo Alto and New York City, on the sale of its majority interest in Blue Stream to GI Partners and Blue Stream’s CEO Joe Canavan. Lawyers Kevin Mills and Maureen Nagle led the Cooley team.

Read more

Related contacts

Kevin Mills
Senior Counsel, Washington, DC
Maureen Nagle
Special Counsel, Washington, DC
Lila Inman
Associate, Reston
William Corcoran
Of Counsel, Boston

Related Practices & Industries

Gray Television Acquires Raycom for $3.6 Billion

July 11, 2018

Cooley advised Gray Television on its agreement to combine with Raycom Media for $3.65 billion in total proceeds.

Read more

Related contacts

Kevin Mills
Senior Counsel, Washington, DC
Maureen Nagle
Special Counsel, Washington, DC
Michael Basile
Senior Counsel, Washington, DC
Henry Wendel
Special Counsel, Washington, DC
Christian Pena
Paralegal Specialist, Washington, DC
Robert M. McDowell
Partner, Washington, DC
Stephanie Gentile
Partner, New York
Parker Erkmann
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

New York